New England Journal of Medicine2007Open AccessHighly Cited

Metabolic Effects of a Growth Hormone–Releasing Factor in Patients with HIV

Julian Falutz, Soraya Allas, K Blot et al.

306 citations2007Open Access — see publisher for license terms1 related compound

Research Article — Peer-Reviewed Source

Original research published by Falutz et al. in New England Journal of Medicine. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.

Abstract

Daily tesamorelin for 26 weeks decreased visceral fat and improved lipid profiles, effects that might be useful in HIV-infected patients who have treatment-associated central fat accumulation. (ClinicalTrials.gov number, NCT00123253 [ClinicalTrials.gov] .).

Full Text

Full text is available at the publisher.

Read at Publisher
Article Details
DOI10.1056/nejmoa072375
JournalNew England Journal of Medicine
Year2007
AuthorsJulian Falutz, Soraya Allas, K Blot, Diane Potvin, Donald P. Kotler, Michael Somero, Daniel Berger, Stephen Brown, Gary Richmond, Jeffrey Fessel, Ralph R. Turner, Steven Grinspoon
LicenseOpen Access — see publisher for license terms
Citations306